coronary artery disease

The NIH Trial to Assess Chelation Therapy (TACT): an unethical s...

Health Care Renewal  Fri, 05/16/2008 - 07:00

Two occasional HCR bloggers are co-authors of an article published this week:

Why the NIH Trial to Assess Chelation Therapy (TACT) Should Be Abandoned
Kimball C.

Atwood IV, MD; Elizabeth Woeckner, AB, MA; Robert S. Baratz, MD, DDS, PhD; Wallace I. Sampson, MD
Medscape J Med. 2008;10(5):115.

©2008 Medscape
Posted 05/13/2008


 

Patients arriving at hospitals in off hours get slower, less car...

EurekAlert! - Medicine and Health  Sun, 04/20/2008 - 23:00

Heart attack patients arriving at hospitals at night, weekends or holidays were slightly less likely to receive emergency angioplasty or receive it in a timely fashion.Death rates were similar for those arriving during regular and off-hours.

Data is of patients treated at hospitals using the American Heart Associations' Get With The Guidelines-Coronary Artery Disease quality improvement program.


 

Mental stress reduces blood flow to the heart in patients with g...

EurekAlert! - Medicine and Health  Mon, 04/14/2008 - 23:00

University of Florida researchers induced stress in 148 patients with coronary artery disease by asking them to speak in public.

Those with a particular gene variation were three times more likely to experience dangerous decreases in blood flow to the heart during stress.


 

Matrix registry probes adherence to clopidogrel at 1 year

EurekAlert! - Medicine and Health  Sun, 03/30/2008 - 23:00

A large community-based registry of patients treated with drug-eluting stents is providing important insight into how long patients with complex coronary artery disease typically stick to their doctors' orders to take clopidogrel, a drug that prevents unwanted blood clots; why they stop taking the drug; and the long-term consequences of that decision.


 

Heart Failure Increases Risk in Noncardiac Surgery

MedPage Today Surgery  Thu, 03/27/2008 - 14:23

DURHAM, N.C. -- Heart failure patients who undergo major noncardiac surgery are at greater risk of operative mortality and hospital readmission than are patients with coronary artery disease, investigators here have concluded.


 

Women are treated less frequently than men with statins, aspirin...

EurekAlert! - Medicine and Health  Mon, 03/03/2008 - 23:00

Women and men experience a similar prevalence of adverse drug reactions in the treatment of coronary artery disease; however, women are significantly less likely than their male counterparts to be treated with statins, aspirin, and beta-blockers according to a new study by researchers at Rush University Medical Center.

The study is published in the March issue of the journal Gender Medicine.